In the US, Femara (letrozole systemic) is a member of the following drug classes: aromatase inhibitors, hormones/antineoplastics and is used to treat Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Metastatic and Female Infertility.
- FEMARA 2.5 MG TABLETS (Leaflet)
- FEMARA 2.5MG FILM-COATED TABLETS (Leaflet)
- FEMARA 2.5MG TABLETS (Leaflet)
Ingredient matches for Femara
Letrozole is reported as an ingredient of Femara in the following countries:
- Bosnia & Herzegowina
- Croatia (Hrvatska)
- Czech Republic
- Hong Kong
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.